Delivery Order SPE2DB24D3013-SPE2DB26FFFWP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,621.52 by the Defense Logistics Agency on August 11, 2025, for Freestyle Libre 3 Plus Sensors. The contract employs firm fixed pricing and is scheduled for completion by August 12, 2025. This award was made on a competitive basis with no set-aside designation. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $3,301.71 by the Defense Logistics Agency for Freestyle Libre 3 Plus Sensors. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of July 22, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $11,821.04 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Freestyle Libre 3 Plus Sensors. The contract is firm fixed price with an ultimate completion date of August 11, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order is issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors valued at $31,084.20. This competitively awarded, firm fixed-price delivery order is set to be completed by September 11, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract action under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $2,002.08 by the Defense Logistics Agency on August 28, 2025, for the supply of Freestyle Libre 3 Sensors. This contract, which represents a competitive award with no set-aside designation, is set to be completed by August 29, 2025. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,072.32 by the Defense Logistics Agency (DLA) on September 19, 2025, for the supply of Freestyle Libre 3 Plus Sensors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by September 22, 2025, and represents a continuation of AmerisourceBergen's extensive relationship with DLA's medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,403.38 by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. The order was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 29, 2025. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $38,788.88 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 19, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $12,967.88 by the Defense Logistics Agency (DLA) on September 17, 2025, with completion expected by September 18, 2025. The contract covers the supply of FreeStyle Libre 3 Plus Sensors, continuous glucose monitoring devices used for diabetes management. This delivery order is classified as firm fixed price with no set-aside designation, indicating competitive award. The place of performance is the contractor's corporate office...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of FreeStyle Libre 3 glucose monitoring sensors. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $11,677.44 and is set to conclude by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract action, this delivery order is issued...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB26FFFWPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,007.06 by the Defense Logistics Agency on October 27, 2025, for the supply of FreeStyle Libre 3 Plus continuous glucose monitoring sensors. The contract, which is not set-aside, utilizes firm fixed-price pricing and carries an ultimate completion date of October 28, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion master contract running through December 2026 that serves as the primary vehicle for supplying pharmaceutical products and medical devices to military and federal healthcare systems worldwide. The FreeStyle Libre 3 Plus sensors represent diabetes care management products critical to military medical readiness and support for servicemembers and beneficiaries requiring continuous glucose monitoring. AmerisourceBergen's role as a prime vendor through the DLA Troop Support Medical contract positions the company as a key supplier within the Defense Health Agency's pharmaceutical supply chain, enabling rapid fulfillment of medical procurement needs across the military healthcare system. The non-competitive nature of this delivery order reflects the established relationship under the parent IDC, which streamlines federal procurement for essential medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 10/27/25 |